 TFF Pharmaceuticals, Inc. NASDAQ:TFFP Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO Director Kirk Coleman - CFO, Treasurer Secretary Christopher Cano - COO VP, Business Development Bill Williams - University of Texas, Austin Dale Christensen - Head, Clinical Development Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Daniel Carlson - TW Research Yuan Zhi - B. Riley Securities Richard Deutsch - National Securities. 